Steps to Derive and Justify Novel Outcomes in Real World Evidence Studies Using Claims or Electronic Health Records
Author(s)
Discussion Leader: Mary E Ritchey, PhD, MSPH, FISPE, CERobs Consulting, LLC, Philadelphia, PA, USA
Discussants: Cynthia J Girman, DrPH, FISPE, CERobs Consulting, LLC, Wrightsville Beach, NC, USA; Josephine Norquist, MS, Merck & Co., Inc, West Point, PA, USA
PURPOSE:
DESCRIPTION:
Attendees will obtain a working knowledge of methods for RWE outcome validation as well as for developing health measurements, drawing from the paradigm of clinical outcome assessments (COAs).
Dr. Ritchey will introduce the importance of rigorous development and validation of outcome measurements in studies using RWE (15 min.). Ms. Norquist will discuss traditional approaches to developing health measurements, including COAs beginning with identifying relevant and feasible concept of interest and derivation of measures relevant to patients, and she will review what constitutes good measurement properties and interpretation for COAs that are meaningful to patients (15 min.). Dr. Girman will propose steps for development and justification to support use of outcomes that are fit-for-purpose for specific RWE study objectives (15 min).
Conference/Value in Health Info
Code
304
Topic
Study Approaches
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now